InvestSMART

AFT Pharmaceuticals Limited (ASX: AFP) - Share Price

Current share price for AFP : $3.140 0.1 (3.29%)+

AFT Pharmaceuticals Limited (AFP), an ASX-listed company, is a New Zealand-based multinational pharmaceutical company that develops, markets, and distributes a portfolio of products across multiple therapeutic categories. These products are available through all pharmaceutical distribution channels, including over the counter (OTC), prescription, and hospital sectors.

AFP General Information +

ASX Code AFP
Website http://www.aftpharm.com
Industry/Sector Pharmaceuticals
Market Cap ($M) 329
AFP Share Price $3.140
Day High $3.140
Day Low $3.040
Last Close $3.040
AFP Share Price Movement $0.10 ( 3.29% )
Prices as at 16:40, 7 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

AFT Pharmaceuticals Limited (AFP) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 1.35¢ 0% 18 Jun 2026 3 Jul 2026 - - -
HFResult 1.11¢ 0% 18 Jun 2025 4 Jul 2025 - - -
HFResult 0.98¢ 0% 19 Jun 2024 4 Jul 2024 - - -

See all dividends from AFT Pharmaceuticals Limited (AFP) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

AFT Pharmaceuticals Limited (AFP) price-sensitive announcements

AFP - Dividend distribution update
AFT Pharmaceuticals Limited announced a final dividend distribution for the financial year
AFT Pharmaceuticals Limited (AFP)
21 May 2026 | 10:07 AM
AFP - FY26 NZX App2
AFT Pharmaceuticals Limited announced its financial results for the year ending 31 March 2
AFT Pharmaceuticals Limited (AFP)
21 May 2026 | 7:31 AM
AFP - FY26 Annual Report
The AFT Pharmaceuticals Limited FY26 Annual Report highlights a successful year ending Mar
AFT Pharmaceuticals Limited (AFP)
21 May 2026 | 7:30 AM
AFP - FY26 results presentation
AFT Pharmaceuticals Limited reported a significant year of growth in FY26 with total sales
AFT Pharmaceuticals Limited (AFP)
21 May 2026 | 7:30 AM

AFT Pharmaceuticals Limited (AFP) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
AFT Pharmaceuticals Limited (AFP)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
 Health Care $329 AFT reports ongoing sales growth and R&D progress 7 Jul 2026 7:30AM $3.040 $3.140 risen by 3.29%
AFT Pharmaceuticals Limited (AFP)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
 Health Care $329 Notice of Annual Meeting of Shareholders 2026 2 Jul 2026 3:17PM $3.010 $3.140 risen by 4.32%
AFT Pharmaceuticals Limited (AFP)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
 Health Care $329 Update - Dividend/Distribution - AFP 24 Jun 2026 1:54PM $3.040 $3.140 risen by 3.29%
AFT Pharmaceuticals Limited (AFP)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
 Health Care $329 FDA allows AFT injectable iron project clinical study 24 Jun 2026 7:31AM $3.010 $3.140 risen by 4.32%
AFT Pharmaceuticals Limited (AFP)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
 Health Care $329 FDA allows AFT injectable iron project clinical study 24 Jun 2026 7:31AM $3.010 $3.140 risen by 4.32%
AFT Pharmaceuticals Limited (AFP)
ORDINARY FULLY PAID FOREIGN EXEMPT NZX
 Health Care $329 Application for quotation of securities - AFP 22 Jun 2026 8:13AM $3.010 $3.140 risen by 4.32%

AFP Financial Summary

Year to Mar NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A $11.74 $11.70 12.90% 22.80 2.10 0.80% 0.0%
2025A $10.36 $10.40 -24.00% 26.20 1.60 0.60% 0.0%
2024A $14.32 $13.70 43.50% 24.00 1.50 0.50% 0.0%

AFP Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
AFT Pharmaceuticals Limited (AFP) $319M 0.1292 0.0000 0.0000 25.9607 0.0000 0.0000 0.68% 0.00% 0.00%
Clarity Pharmaceuticals Ltd (CU6) $981M 0.3002 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Neuren Pharmaceuticals Limited (NEU) $2,111M -0.7857 0.0743 1.2000 71.5514 66.6000 30.2727 0.00% 0.00% 0.00%

AFP Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.32 26.80 3.58 0.00
Market 0.28 13.00 1.15 0.59
Sector 0.45 27.70 2.40 1.86

AFP Directors

Name Position Start Date
Ms Marree Atkinson Chief of Staff, Co-founder, Managing Director 4 Sep 2012
Mr Hartley Atkinson Founder, Chief Executive Officer, Executive Director 4 Sep 1997
Mr David Mark Flacks Non-Executive Chairman, Non-Executive Director 22 Jun 2015
Mr Andrew Michael Lane Non-Executive Director 28 Sep 2023
Dr Ted Witek Non-Executive Director 1 Jan 2021
Ms Allison Yorston Non-Executive Director 12 Nov 2024

AFT Pharmaceuticals Limited (AFP) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
27 Nov 2024 ATKINSON, Hartley Buy Indirect Shares 45 $2.800 $126.000
7 Aug 2020 ATKINSON, Hartley Issued Indirect Shares 137,826 $2.740 $377,643.240
2 Jul 2020 FLACKS, David Buy Indirect Shares 13,333 $3.750 $49,998.750

See all changes in directors' interest & trades for AFT Pharmaceuticals Limited (AFP) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

AFP Management

Name Position
Malcolm Tubby Chief Financial Officer,Company Secretary
Ioana Stanescu Chief Scientific Officer
Louise Clayton Director International Business
Scott Crawford General Manager Promoted Products
Murray Keith Group Marketing Manager
Vladimir Ilievski Regulatory Affairs Manager

AFP Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in AFT Pharmaceuticals Limited (AFP). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
72,259,496 (68.91%) Hartley Campbell Atkinson
7,397,399 (7.05%) Accident Compensation Corporation (ACC)

AFP Calendar of Events

Date Event
20 May 2027 Report (Annual)
20 May 2027 Report (Interim)
20 May 2027 Report (Prelim)
19 November 2026 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.